Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Positive phase III results announced for ophthalmic implant for diabetic macular edema

June 12, 2002

CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD

June 3, 2002

Japanese labs identify new antiglaucoma agents

May 15, 2002

U.S. researchers successfully design soft cannabinoid analogues with potential in glaucoma Rx

May 14, 2002

Adenoviral gene transfer of PEDF inhibits choroidal neovascularization in animal models

May 9, 2002

Cannabinoid agonist reduces IOP by decreasing aqueous humor flow

May 9, 2002

Rights to angiotensin II receptor blocker for glaucoma licensed to Santen

May 9, 2002

Squalamine reported to have beneficial effects in animal model of wet AMD

May 8, 2002

Sustained transcleral delivery of EYE-001 achieved using PLGA microspheres

May 8, 2002

Postoperative CAT-152 superior to 5-FU in preventing scarring after glaucoma filtration surgery

May 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...